A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

NCT03470103 · clinicaltrials.gov ↗

COMPLETED

Status

643

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)

Sponsor

Bayer